Thibaut du Fayet

Vice President, Alliance Management, Project Management & Marketing at Transgene SA

Thibaut du Fayet

Thibaut du Fayet

Vice President, Alliance Management, Project Management & Marketing at Transgene SA

Biography

Thibaut du Fayet joined Transgene in 2008 and is in charge of project management, alliance management and marketing at Transgene. From 2007 to 2008, he was responsible for marketing at Stallergenes. Prior to that, he held various positions in corporate strategy and business development at bioMérieux (2003 -2007) and Rhodia/Rhone-Poulenc (1999-2003). Prior to his industry experience, he spent six years working as a Management Consultant at Bossard/Gemini Consulting. Thibaut du Fayet has an MBA from ESSEC Management School and holds an MA in International Finance from Brandeis University (Boston).

Overview
RelSci Relationships

103

Number of Boards

2

Birthday

1968

Age

53

Relationships
RelSci Relationships are individuals Thibaut du Fayet likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at TSGH SAS

Relationship likelihood: Strong

Chief Executive Officer at SparingVision SAS

Relationship likelihood: Strong

Vice President-Responsible Pharmacist, Quality & Deputy Chief Executive Officer, Member of the Management Committee at Transgene SA

Relationship likelihood: Strong

Deputy Chief Executive Officer, Director-Research & Development at Transgene SA

Relationship likelihood: Strong

Vice President, Finance at Transgene SA

Relationship likelihood: Strong

Vice President, Corporate Development & Medical Affairs at Transgene SA

Relationship likelihood: Strong

Director Général, ABL Europe at Advanced Bioscience Laboratories, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Modra Pharmaceuticals BV

Relationship likelihood: Strong

Former Director-Quality Assurance & Compliance at Transgene SA

Relationship likelihood: Strong

Vice President, Corporate Secretary & General Counsel at Transgene SA

Relationship likelihood: Strong

Paths to Thibaut du Fayet
Potential Connections via
Relationship Science
You
Thibaut du Fayet
Vice President, Alliance Management, Project Management & Marketing at Transgene SA
Education

ESSEC has been developing a state-of-the-art educational program that gives the individual pride of place in its learning model, promoting the values of freedom, openness, innovation and responsibility. Preparing future managers to reconcile personal interests with collective responsibility, giving consideration to the common good in their decision-making, and weighing economic challenges against the social costs are some of the objectives ESSEC has set for itself. Its ultimate goal? To create a global world that has meaning for us all.

Brandeis University is an American private research university with a liberal arts focus. It is located in Waltham, Massachusetts, 9 miles (14 km) west of Boston. The university has an enrollment of approximately 3,600 undergraduate and 2,200 graduate students.[4] It was tied for 32nd among national universities in the United States in U.S. News & World Report 's 2014 rankings. Forbes listed Brandeis University as number 51 among all national universities and liberal arts colleges combined in 2013. Brandeis was founded in 1948 as a nonsectarian Jewish community-sponsored coeducational institution on the site of the former Middlesex University. The university is named for Louis Brandeis (1856–1941), the first Jewish Justice of the Supreme Court of the United States.

Career History
Vice President, Alliance Management, Project Management & Marketing
2008 - Current

Transgene SA is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of immunotherapies for the treatment of cancer and infectious diseases. Its products include TG4001, TG6002, BT-001 and TG4050. The company was founded in December 1979 and is headquartered in Strasbourg, France.

Head-Marketing
2007 - 2008

Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France.

Boards & Committees
Member, Management Committee
Current

Transgene SA is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of immunotherapies for the treatment of cancer and infectious diseases. Its products include TG4001, TG6002, BT-001 and TG4050. The company was founded in December 1979 and is headquartered in Strasbourg, France.

Director
Prior

Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thibaut du Fayet. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thibaut du Fayet's profile does not indicate a business or promotional relationship of any kind between RelSci and Thibaut du Fayet.